Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Detecting an MCI and Amyloid Digital Neuro Signature(DNS) Using Altoida's Multimodal Digital Biomarkers.
Authors not listed
Altoida · 2024
Abstract
The purpose of this study is to establish multiple points of clinical validity for the Altoida digital biomarker assessment in individuals with a clinical diagnosis of cognitively normal (CN) and Mild Cognitive Impairment (MCI). Participants will use the Altoida app and the de-identified sensor data captured by the device will be used to train specific machine-learning algorithms to recognize early symptoms of cognitive decline, such as MCI or MCI with likelihood of amyloid pathology, as measured by digital biomarkers (T1 - Visit 1). Participants will be invited for an additional visit to evaluate test-retest reliability (T1' - Visit 2). Optionally, an updated variation of the Altoida app will be tested over the course of two additional visits to ensure optimal digital assessment delivery based on best practices in neuropsychological testing, user experience design, and data collection integrity (T2 - Visit 3 and T2' - Visit 4).
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Anonymous. (2024). Detecting an MCI and Amyloid Digital Neuro Signature(DNS) Using Altoida's Multimodal Digital Biomarkers. <em>Altoida</em>. https://clinicaltrials.gov/study/NCT06223438
Vancouver
Anonymous. Detecting an MCI and Amyloid Digital Neuro Signature(DNS) Using Altoida's Multimodal Digital Biomarkers. Altoida. 2024.
BibTeX
@misc{anon2024Detect,
title = {Detecting an MCI and Amyloid Digital Neuro Signature(DNS) Using Altoida's Multimodal Digital Biomarkers.},
author = {Anonymous},
journal = {Altoida},
year = {2024},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Vanderbilt University Medical Center 2022
Open access · US-GOV
Disclosing Dementia Risk Based on Plasma Phosphorylated Tau
Weill Medical College of Cornell University 2026
Open access · US-GOV
Center for Research and Education on Aging and Technology Enhancement - CREATE V
Kessler Foundation 2023
Open access · US-GOV
Use of a Memory Technique to Improve New Learning and Memory in Individuals With Mild Cognitive Impairment
Oregon Health and Science University 2022
Open access · US-GOV
Digital Evaluations and Technologies Enabling Clinical Translation for AD
Biology Methods and Protocols 2025
Open access · CC-BY
A prospective cohort study to develop multi-biomarkers panel to define biological ageing in six different cohorts from newborn to oldest adult: a study protocol
Crown Laboratories, Inc. 2021
Open access · US-GOV